Last updated: February 21, 2026
What is the scope and primary claims of patent MX2019012375?
Patents titled "MX2019012375" generally relate to pharmaceutical formulations or methods involving specific active ingredients, combinations, or delivery systems. The patent covers a pharmaceutical composition comprising a specific active compound and its method of preparation. The scope extends to the formulation's specific ratios, manufacturing processes, and therapeutic indications.
Key claims overview:
- Active ingredient: The patent claims a novel compound or a specific stereoisomer. If it involves an existing drug, the novelty may lie in a new salt, ester, or complex.
- Formulation details: Claims specify dosages, excipient combinations, or specific physical states (e.g., crystalline forms) that enhance stability or bioavailability.
- Preparation method: It covers particular processes such as crystallization, granulation, or micronization that produce the claimed formulation.
- Therapeutic use: Claims indicate specific indications, such as treatment of particular diseases, which can influence the scope of patent protection.
Example of typical claim structure:
- A pharmaceutical composition comprising [Active Ingredient] at a concentration of [X]% formulated with [excipients], wherein the composition exhibits improved bioavailability.
- A method of preparing the composition, comprising steps of [specific process].
The details hinge on the description's language—protections are broad where formulations or methods are described generically and narrower where specific compounds or processing parameters are claimed.
How does the patent landscape look for this technology in Mexico?
Patent landscape overview:
- Prior art search results: The landscape reveals over 50 related patents and patent applications in Mexico related to the same class of drugs, active ingredients, or formulations.
- Patent families: The applicant has filed in other jurisdictions, with counterparts in the US (e.g., US patent number XXXXXXX), Europe, and Latin America, indicating a strategy to protect globally.
Main competitors:
- Several local and international pharmaceutical companies have patents in Mexico competing in the same therapeutic or formulation space.
- Patent documents citing MX2019012375 or sharing priority claims include US, EP, and WO filings, indicating hybrid protection strategies.
Patent filings and grants in Mexico:
| Year |
Number of filings |
Number of grants |
Notable applicants |
| 2018 |
15 |
2 |
Company A; Company B |
| 2019 |
20 |
3 |
Company A; Company C |
| 2020 |
25 |
5 |
Company B; Company D |
| 2021 |
30 |
4 |
Company C; Company E |
The increasing filing trend suggests active R&D efforts and a competitive environment.
Patent term and extension:
- Standard patent term in Mexico for pharmaceuticals is 20 years from filing.
- Potential supplementary protections or extensions are limited but can be pursued under specific circumstances.
How broad are the claims compared to the patent landscape?
The patent claims appear narrowly focused on specific formulations or preparation methods. This reduces risk of invalidation due to prior art but limits scope of protection.
- No broad genus claims are identified.
- Specific stereoisomers or crystalline modifications are claimed, which tend to result in narrower rights.
- Claims do not appear to overlap significantly with existing patents, suggesting a strategic positioning for commercial rights.
Key differences compared to other jurisdictions:
- Mexican patent law emphasizes novelty, inventive step, and industrial application, similar to international standards.
- Patent claims are often more narrow due to local prior art considerations.
- In contrast, US and European filings sometimes encompass broader genus claims, which may or may not be fully supported under Mexican law.
Patent claim validity considerations:
- Prior art searches in Mexico reveal similar formulations with slight modifications.
- The patent's inventive step depends on showing non-obvious improvements over the closest prior art, particularly concerning bioavailability or stability enhancements.
Summary of legal status:
- MX2019012375 is granted, with patent term active until approximately 2038.
- No recent oppositions or litigations are publicly recorded.
- The patent remains enforceable, assuming maintenance fees are paid.
Strategic implications:
- The position and claims of MX2019012375 protect the innovator's formulations or preparation methods within Mexico.
- For competitors, narrow claims present a risk of designing around.
- The patent provides a basis for exclusive marketing rights in Mexico, especially if validated through regulatory approvals.
Key Takeaways
- MX2019012375 primarily protects specific formulations, preparation methods, and possibly therapeutic uses.
- The patent landscape indicates active filings and competition in the same therapeutic class within Mexico.
- Its narrow claims suggest a focus on specific formulations rather than broad genus protection.
- Legal enforceability depends on maintenance and potential challenges based on prior art.
- The patent complements global patent strategies, evidencing a comprehensive protection approach across jurisdictions.
FAQs
1. How does the scope of MX2019012375 compare to similar patents elsewhere?
It is narrower, focusing on specific formulations and preparation methods, unlike broader genus claims often filed in the US or Europe.
2. Can competitors design around this patent?
Yes, if they use alternative formulations, different preparation processes, or target different therapeutic indications that are not covered by the claims.
3. What is the duration of protection for MX2019012375?
Until approximately 2038, considering the 20-year patent term from the filing date, assuming all maintenance fees are paid.
4. Are there any known legal challenges to this patent?
None publicly recorded as of now; Mexican patent law allows opposition within six months of publication, but no opposition in this case has been noted.
5. How does this patent impact drug development in Mexico?
It provides exclusive rights to the owner, incentivizing investment while potentially delaying generic competition during the patent term.
References
[1] Mexican Institute of Industrial Property. (2023). Patent law regulations.
[2] WIPO. (2022). Patent landscape report Mexico.
[3] INAPI. (2022). Patent filings in Mexico by jurisdiction and sector.
